|
| Press Releases |
|
 |
|
| Tuesday, August 13, 2013 |
|
|
New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine |
| A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). more info >> |
|
| Tuesday, August 6, 2013 |
|
|
Unexpected Synergy Between Two Cancer-linked Proteins Offers Hope for Personalised Cancer Therapy |
| A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. more info >> |
|
| Saturday, July 27, 2013 |
|
|
Singapore Scientists Discover New Drug Targets for Aggressive Breast Cancer |
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS.
more info >> |
|
| Tuesday, July 2, 2013 |
|
|
Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells |
| Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. more info >> |
|
| Friday, May 17, 2013 |
|
|
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >> |
|
| Thursday, April 25, 2013 |
|
|
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases |
| The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop(TM), the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. more info >> |
|
| Monday, April 22, 2013 |
|
|
Understanding Abnormal Proteins in Degenerative Diseases |
| Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding abnormal proteins, providing them with the insights required to design more effective treatments for degenerative diseases such as Alzheimer's, diabetes and cancer. more info >> |
|
| Thursday, April 18, 2013 |
|
|
Singapore Scientist Wins Coveted Chen New Investigator Award 2013 |
| Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). more info >> |
|
|
A*STAR Scientists Decipher Genome Code of a Living Fossil |
| An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land. more info >> |
|
| Friday, April 5, 2013 |
|
|
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research |
| Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
「星樞計劃」正式發布 鈞達股份多家下屬公司成為上海太空算力產業生態夥伴發起及首批單位
May 17, 2026 12:51 HKT/SGT
|
|
|
Shoucheng Holdings' First-Quarter Report Shows 18% Core Profit Growth and Sustained High Shareholder Returns
May 16, 2026 08:49 HKT/SGT
|
|
|
首程控股一季報核心利潤增長18% 高股東回報持續兌現
May 16, 2026 08:49 HKT/SGT
|
|
|
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform
May 16, 2026 07:00 HKT/SGT
|
|
|
Substantial Shareholder Wei Fu Increases Shareholding in Everest Medicines Again, Marking His Second Share Purchase in 2026 and Demonstrating Long-term Confidence
May 15, 2026 22:20 HKT/SGT
|
|
|
NEC completes construction of approximately 2,250 km EMCS submarine cable linking Pacific island nations
May 15, 2026 17:36 JST
|
|
|
Fujitsu and Science Tokyo launch joint research hub for quantum hardware advancement and talent development
May 15, 2026 17:12 JST
|
|
|
Fujitsu and IBM Japan formalize collaboration in healthcare sector
May 15, 2026 16:42 JST
|
|
|
三菱重工機械システム、関越自動車道での交通混雑緩和キャンペーンに協力
May 15, 2026 15:30: JST
|
|
|
富士通と東京科学大学、量子ハードウェア技術の進展と人材育成に向けた共同研究を開始
May 15, 2026 15:30: JST
|
|
|
Toyota Launches All-New Land Cruiser "FJ" Series in Japan
May 15, 2026 15:24 JST
|
|
|
Mitsubishi Motors Signs Memorandum of Understanding with FPT Japan Holdings to Study Collaboration in Software and Digital Domain
May 15, 2026 15:10 JST
|
|
|
Your Go-To Travel Checklist for Smarter, Reward-Focused Travel Planning
May 15, 2026 14:00 HKT/SGT
|
|
|
NEC Launches Orbital Transfer Vehicle Development Project Aiming for Asia's First Vehicle Deployment through JAXA's Space Strategy Fund Program
May 15, 2026 14:55 JST
|
|
|
雲頂新耀主要股東傅唯再度增持 年內第二次加倉彰顯長期信心
May 15, 2026 13:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
